Healthcare Reports

Global Ovarian Cancer Diagnostics Market Size, Trends, and Analysis - Forecasts to 2026 By Diagnosis (Imaging [Ultrasound, CT scan, MRI Scan, PET Scan, Others], Blood Test [CA125, HER2, BRCA, CEA, ER & PR, KRAS Mutation, Others], Biopsy, Others), By Cancer Type (Epithelial Tumor, Germ Cell Tumor, Stromal Cell, Others), By End-Use (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The global ovarian cancer diagnostics market is projected to grow from USD 25.0 billion in 2021 to USD 36.5 billion by 2026 at a CAGR value of 7.5%. Factors like the rising prevalence of ovarian cancer, rising consumption of unhealthy foods, increasing chronic disorders related to the reproductive organ, technological advancements in cancer diagnosis, rising awareness regarding pre-disease diagnosis and other health concerns, non-invasive nature of the technique to detect the tumor will help the market grow rapidly from 2021 to 2026. Read More »


July 5 : 2021

Global Cardiac Monitoring Devices Market Size, Trends & Analysis - Forecasts to 2026 By Product (ECG Monitor, Event Recorder, Implantable Cardiac Loop Recorder, Pacemaker, Defibrillator, Cardiac Resynchronization Therapy (CRT), Smart Wearable, Others), By End-User (Homecare, Hospitals & Clinics, Others), Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

The global cardiac monitoring devices market is projected to grow from USD 22.1 billion in 2021 to USD 26.8 billion by 2026 at a CAGR value of 4.0%. Growing incidences of cardiovascular diseases and the growing demand for homecare among patients have been the major drivers of the cardiac monitoring market. Read More »


July 5 : 2021

Global Infectious Disease Therapeutics Market Size, Trends & Analysis - Forecasts to 2026 By Disease Type (HIV infection, Influenza, Malaria, Tuberculosis, Hepatitis, and HPV infection), By Mode of Treatment (Drugs, Vaccines), By Drug Class (Anti-Bacterial, Anti-Viral, Anti-Parasite, Anti-Fungal, Others), By End-User (Hospital Pharmacy, Retail Pharmacy, Others), By Region (North America, Europe, Asia Pacific, Central & South America, Middle East & Africa); Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

The global infectious disease therapeutics market is expected to grow from USD 48.77 billion in 2021 to USD 57.21 billion in 2026, at a CAGR of 7.12%. The market drivers which contribute to the infectious disease therapeutics market growth include rising infectious disease, an increasing number of surgeries, high prevalence of chronic diseases such as cardiovascular and cancer, rising cases of accidents, changing food habits, lack of proper sanitation measures taken by healthcare providers, and personal unhygienic conditions, lack of antibodies & immunity, and growing patient pool. Read More »


July 2 : 2021

Global Comprehensive Metabolic Panel Testing Market Size, Trends, and Analysis - Forecasts To 2026 By Disease (Kidney Disease, Liver Disease, Diabetes, Others), By End-Use (Laboratories, PoC), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

The global comprehensive metabolic panel testing market will grow from USD 11.5 billion in 2021, to USD 13.8 billion in 2026 with a CAGR value of 7.5%. Increasing prevalence of cardiovascular diseases and diabetes, the emergence of automated systems in laboratories, efficient and rapid results, development of data management solutions and introduction of innovative solutions for enhancing efficiency and minimizing errors are expected to increase demand for the comprehensive metabolic panel testing market. Read More »


July 2 : 2021

Global Glucose Analyzers Market Size, Trends & Analysis - Forecasts to 2026 By Product Type (Handheld POC Glucose Analyzer and Benchtop POC Glucose Analyzer); By Sample (Blood and Saliva); By End-User (Hospitals, Office based Settings, Home Care Settings, Clinics and Ambulatory Surgical Centres); By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

The global glucose analyzers market is expected to grow from USD 12.45 billion in 2021 to USD 18.05 billion in 2026 at a CAGR of 7.6% during the forecast period. The glucose analyzers market will grow rapidly mainly due to the rising demand for home-based glucose testing devices and the rising adoption of innovative technologies by hospitals and diagnostic laboratories. The Read More »


July 1 : 2021

Global Reusable Autoinjectors Market Size, Trends & Analysis - Forecasts to 2026 By Dose (Fixed and Variable), By Technology (Smart Autoinjectors, Conventional Autoinjectors) By Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Others), By End-User (Homecare, Ambulatory Care, Hospitals & Clinics), Competitive Landscape Company Market Share Analysis, and Competitor Analysis

The global reusable autoinjectors market is projected to grow at a CAGR value of 11.7% during the forecast period [2021 to 2026]. Reusable autoinjectors are becoming increasingly popular among patients suffering from diseases that require multiple injection doses in a day. Read More »


June 30 : 2021